Loading…

Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion

Abstract Hepatitis B reactivation in hepatitis B surface antigen (HBsAg)-negative and anti-HBsAg antibodies-positive patients is an infrequent complication of chemotherapy, usually with fatal evolution. Here we report an HBsAg-negative patient with a myelodysplastic syndrome, who developed hepatitis...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic microbiology and infectious disease 2009-05, Vol.64 (1), p.80-82
Main Authors: PEREZ-GRANDE, Rosa, GUTIERREZ-ZUFIAURRE, Nieves, MUNOZ-CRIADO, Santiago, BLAZQUEZ DE CASTRO, Ana M, VAZQUEZ LOPEZ, Lourdes, SAN MARTIN, Francisco Gonzalez, GARCIA RODRIGUEZ, Jose Angel, MUNOZ BELLIDO, Juan Luis
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Hepatitis B reactivation in hepatitis B surface antigen (HBsAg)-negative and anti-HBsAg antibodies-positive patients is an infrequent complication of chemotherapy, usually with fatal evolution. Here we report an HBsAg-negative patient with a myelodysplastic syndrome, who developed hepatitis B reactivation after chemotherapy and evolved favorably after lamivudine treatment, allowing seroconversion.
ISSN:0732-8893
1879-0070
DOI:10.1016/j.diagmicrobio.2009.01.007